IDX Integral Diagnostics Limited
Healthcare · Diagnostics & Research
· website
· 3,049 employees
$2.15
52wk 1.91 – 2.76
Overall
45.4
Value
61.2
Growth
78.9
Health
23.2
Quality
26.1
Momentum
30.6
Dividend
42.1
Price
About Integral Diagnostics Limited
Integral Diagnostics Limited, a healthcare services company, provides diagnostic imaging services to general practitioners, medical specialists, allied health professionals, and patients in Australia and New Zealand. It offers medical diagnostic imaging services, such as magnetic resonance imaging, computed tomography, mammography, ultrasound, and radiography, as well as nuclear medicine, including positron emission tomography. The company was founded in 1967 and is headquartered in East Melbourne, Australia.
Price analytics
Returns
| 1 day | 0.9% |
| 1 week | -2.7% |
| 1 month | -5.7% |
| 3 months | 2.4% |
| 6 months | -6.5% |
| 1 year | -20.7% |
| 3 years | -22.9% |
Risk
| Volatility (1y ann.) | 27.9% |
| Beta vs ASX 200 | 0.66 |
| Sharpe (1y) | -0.83 |
| VaR 95% (1-day) | -2.9% |
| Max drawdown (1y) | -29.2% |
| Off 1-year high | -21.5% |
Technicals
| RSI(14) | 30 OS |
| vs 50DMA | -4.0% |
| vs 200DMA | -5.5% |
| Trend | Death cross |
Fundamental trends
Financial statements
Loading…
Scoring breakdown
(2 Oct 2026)
Value
61.2
Trailing P/E
13
Forward P/E
78
PEG ratio
—
EV / EBITDA
50
Price / Book
95
Price / Sales
98
Growth
78.9
Revenue growth (1y)
100
Revenue CAGR (3y)
100
EPS growth (1y)
100
EPS CAGR (3y)
0
Financial Health
23.2
Net debt / EBITDA
0
Interest coverage (EBIT/interest)
26
Current ratio
0
Debt / Equity
62
Quality (Profitability & Cash Flow)
26.1
Return on equity
16
Return on assets
32
Operating margin
41
Net margin
18
Cash conversion (OCF / net income)
—
Dividend / Income
42.1
Dividend yield (%)
73
Payout ratio
0
FCF dividend cover
56
Momentum
30.6
6-month return vs ASX 200
31
Price vs 200-day average
32
Price vs 50-day average
30
Position in 52-week range
29
Hover a row's info icon for the exact rule. Bounds and weights are configurable in the Django admin (Scoring configuration).
Score history
Key metrics
Market cap
$802.09M
P/E (trailing)
35.83
P/E (forward)
13.84
EPS (trailing)
0.06
Dividend yield
4.3%
Payout ratio
125.9%
Beta
0.14
EV / EBITDA
12.03
Price / Book
1.18
ROE
3.2%
Operating margin
10.3%
Net margin
2.8%
Total cash
$51.29M
Total debt
$597.10M
Current ratio
0.67
Debt / Equity
0.88
Free cash flow
$53.54M
Avg volume
1.02M
Latest annual results
(FY ending 30 Jun 2026)
- Revenue$788.62M
- Gross profit$752.67M
- Operating income$68.44M
- Net income$21.93M
- Diluted EPS0.06
- Free cash flow$45.60M
- Net debt$545.81M